Homocyst(e)ine levels in patients on phenytoin therapy

被引：24

作者：

James, GK

Jones, MW

Pudek, MR

机构：

[1] Vancouver Hosp & Hlth Sci Ctr, Dept Pathol & Lab Med, Div Clin Chem LSP1, Vancouver, BC V5Z 1L8, Canada

[2] Vancouver Hosp & Hlth Sci Ctr, Dept Med, Div Neurol, Vancouver, BC V5Z 1L8, Canada

[3] Univ British Columbia, Vancouver, BC V5Z 1L8, Canada

来源：

CLINICAL BIOCHEMISTRY | 1997年 / 30卷 / 08期

关键词：

D O I：

10.1016/S0009-9120(97)00116-1

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：647 / 649

页数：3

共 13 条

[1] HEART-DISEASE MORTALITY AND MORBIDITY IN PATIENTS WITH EPILEPSY [J].

ANNEGERS, JF ;

HAUSER, WA ;

SHIRTS, SB .

EPILEPSIA, 1984, 25 (06) :699-704

[2]

[Anonymous], 1977, Statistical Methods in Medical Research

[3]

BILLINGS RE, 1984, MOL PHARMACOL, V25, P459

[4] A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].

BOUSHEY, CJ ;

BERESFORD, SAA ;

OMENN, GS ;

MOTULSKY, AG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057

[5] Hyperhomocysteinemia as a risk factor for deep-vein thrombosis [J].

denHeijer, M ;

Koster, T ;

Blom, HJ ;

Bos, GMJ ;

Briet, E ;

Reitsma, PH ;

Vandenbroucke, JP ;

Rosendaal, FR .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (12) :759-762

[6] MEASUREMENT OF HOMOCYST(E)INE IN THE PREDICTION OF ARTERIOSCLEROSIS [J].

FORTIN, LJ ;

GENEST, J .

CLINICAL BIOCHEMISTRY, 1995, 28 (02) :155-162

[7]

FROSCHER W, 1995, CLIN NEUROPHARMACOL, V18, P165

[8]

Guba SC, 1996, AM J CLIN PATHOL, V106, P709

[9] PHENYTOIN-FOLIC ACID INTERACTION [J].

LEWIS, DP ;

VANDYKE, DC ;

WILLHITE, LA ;

STUMBO, PJ ;

BERG, MJ .

ANNALS OF PHARMACOTHERAPY, 1995, 29 (7-8) :726-735

[10] CASE-CONTROL STUDY OF ASSOCIATED CONDITIONS AT THE TIME OF DEATH IN PATIENTS WITH EPILEPSY [J].

SATISHCHANDRA, P ;

CHANDRA, V ;

SCHOENBERG, BS .

NEUROEPIDEMIOLOGY, 1988, 7 (03) :109-114

← 1 2 →